Our legal team is currently investigating lawsuits related to Ozempic, focusing on patients who developed NAION, gastroparesis, or other gastrointestinal issues like bowel obstruction or cyclic vomiting syndrome. Ozempic, a well-known brand name for semaglutide, is a prescription drug approved for type-2 diabetes treatment and often used for weight management. Recent research has linked Ozempic, especially at higher doses, to conditions like gastroparesis.

​

Previously, Ozempic's warning label did not adequately inform patients or doctors about these potential risks. Individuals who have suffered harm after taking Ozempic may be eligible to pursue financial compensation through product liability lawsuits.

There are also lawsuits involving other drugs such as Rybelsus, Wegovy, Trulicity, and Mounjaro, which, as of February 2024, have been consolidated into a class action MDL. This page will provide ongoing updates on the Ozempic litigation and offer insights into potential settlement values.

Our Ozempic Lawyers Are Taking 8 Types of Claims

1. Gastroparesis or stomach paralysis

2. Hospitalization for over one day for GI issues

3. Esophageal injury requiring surgery

4. Ileus or bowel obstruction

5. NEW: Sudden Vision Loss or NAION (nonarthritic anterior ischemic optic neuropathy)

6. DVT and related injuries, including death

7. Pulmonary aspiration

8. Gallbladder injury with surgery (Started taking drug prior to 2022)

If you have an Ozempic lawsuit, fill out this form for a free consultation.

​

Estimated Settlement Amounts for an Ozempic Lawsuit

Estimating the potential settlement value of new product liability cases like this is almost impossible to do with any real accuracy. That is particularly true with the Ozempic gastroparesis lawsuits because they are very new. At this point, we don’t know how the scientific evidence behind these cases is going to hold up in court. That is a major variable in any defective drug case.

​

Still, victims want to know how much the Ozempic lawsuit is going to payout? So what our lawyers can do, however, is provide an educated guess as to the possible settlement compensation payout range of Ozempic cases based on various assumptions about the causation evidence. Based on these significant assumptions, our attorneys believe that a successful Ozempic lawsuit could have a settlement value range of $400,000 to $700,000. This is the settlement value estimate for the “top tier” Ozempic cases, which would be those in which the plaintiff suffered severe gastroparesis or death.

​

Practical Reasons That May Drive Settlement

The financial outlook of the pharmaceutical market indicates that significant settlement payouts may be likely in the ongoing Ozempic-related litigation. Companies profiting heavily from drugs like Ozempic, Rybelsus, Wegovy, Trulicity, and Mounjaro are well-positioned to absorb substantial settlement costs without jeopardizing their financial health.

​

Historically, pharmaceutical companies tend to extend litigation and are often indifferent to the potential reputational damage caused by adverse verdicts. However, this situation is different. These companies are more concerned about protecting the reputation of these highly profitable drugs and ensuring continued sales.

​

The massive profits these drugs generate could alter their usual litigation strategy. Settling claims quickly may become a more attractive option to safeguard their earnings and avoid the public relations fallout from a high-profile verdict. Such a verdict could expose further damaging evidence, increasing the risk of even larger claims or punitive damages.

Given this context, it's expected that these companies may opt for significant early settlements to minimize reputational harm and the financial uncertainties that come with prolonged jury trials.

​

Weight Loss Lawsuits May Have Higher Values than for Diabetes

We anticipate that injury lawsuits for patients using Ozempic and similar drugs for diabetes will likely result in substantial compensation if the claims are valid. However, settlements in cases involving Ozempic for weight loss may be larger than those for diabetes, due to several factors.

​

First, weight loss patients tend to come from a different demographic, often younger individuals who may suffer long-term or more severe side effects, which increases the potential damages. In mass tort cases, younger plaintiffs typically receive higher settlements than older ones.

​

Second, the expectations and marketing surrounding weight loss drugs can place a higher duty of care on pharmaceutical companies to disclose risks. Failing to adequately warn about side effects for a lifestyle drug like Ozempic, which is seen as more optional than a diabetes medication, could result in greater liability. Jurors might find this failure to warn more serious in cases where the drug is used for cosmetic purposes, leading to stronger claims and even the possibility of punitive damages.

​

Additionally, weight loss patients often don’t have the same pre-existing health conditions as diabetes patients, making it easier to directly link side effects to the medication. While defense attorneys may try to shift blame onto patients, clearer causation in these cases strengthens claims and could influence larger settlements.

​

Hiring an Ozempic Lawyer

If you have an Ozempic gastroparesis lawsuit,  reach out to us online for a free consultation.